Annual School of Nursing Oncology

Approaches to Urothelial Care Call for Nuanced AE Management

August 11, 2022

Avelumab, erdafitinib, and enfortumab vedotin-ejfv are 3 critical drugs in the treatment of urothelial cancer with distinct safety profiles, according to a presentation at the 6th Annual School of Nursing Oncology™ Meeting.